A proteomic profile correlates with salivary gland inflammation and disease-associated antibodies in Sjögren’s disease
Year: 2025
Type: article
Study design: Observational Study
Abstract: OBJECTIVES: To identify serum and salivary gland proteomic biomarkers in primary Sjögren's disease (SjD), evaluate their correlation with tissue inflammation, and relate findings to clinical, autoantibody, and genetic profiles. METHODS: Paired salivary gland extracts and serum samples from patients with SjD (n = 81) and sicca controls (n = 19), and serum from larger Swedish (SjD n = 456; controls n = 141) and Norwegian (SjD n = 233; controls n = 137) cohorts, were analysed using proximity extension assay technology. Patients were stratified by antinuclear antibodies (ANA), anti-Ro/SSA, anti-La/SSB autoantibodies, and extraglandular manifestations. Human leukocute antigen (HLA) alleles were integrated to assess genetic associations. RESULTS: Proteomic analysis revealed more pronounced alterations in the salivary gland extracts compared to serum. In serum, 27 proteins were associated with SjD in the Swedish discovery cohort, of which 16 proteins were validated in the Norwegian replication cohort. Several proteins including both described biomarkers C-X-C motif chemokine ligand (CXCL)10 and CXCL13 and more novel lysosome-associated membrane glycoprotein 3 and cytotoxic and regulatory T cell molecule correlated with extraglandular manifestations, particularly pulmonary involvement. Levels of the 16 validated proteins increased in a stepwise fashion across serological subgroups, from lowest in ANA negative to highest in anti-Ro/SSA and anti-La/SSB double-positive patients and were linked to risk alleles HLA-DRB1*03 and DRB1*15. A composite 'Sjögren protein score' based on the 16 validated proteins correlated with salivary gland focus score and successfully distinguished SjD from healthy controls (area under the curve 0.888; 89% specificity, 76% sensitivity). CONCLUSIONS: We define a validated serum proteomic signature that reflects local glandular inflammation and correlates with genetic and serological features. The 'Sjögren protein score' holds promise as a noninvasive biomarker for the diagnosis of SjD.
Source: Annals of the Rheumatic Diseases
Authors: Albin Björk, Johannes Mofors, Lauro Meneghel, Marika Kvarnström, Elisabeth Maeland, Elina Richardsdotter Andersson, Roland Jonsson, Roald Omdal, Helena Forsblad-d’Elia, Sara Magnusson Bucher, Per Eriksson, Thomas Mandl, Peter Olsson, Marie Fischer, Katrine B Norheim, Svein Joar Auglænd Johnsen, Daniel Hammenfors, Kathrine Skarstein, Malin V Jonsson, Silke Appel, Ingrid Kockum, Juliana Imgenberg-Kreuz, Gunnel Nordmark, Marie Wahren-Herlenius
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,870
Funders: Åke Wiberg Stiftelse, Tore Nilsons Stiftelse för Medicinsk Forskning, European Federation of Pharmaceutical Industries and Associations, European Commission, Hjärt-Lungfonden, Knut och Alice Wallenbergs Stiftelse, Stockholms Läns Landsting, Vetenskapsrådet, Stiftelsen Lars Hiertas Minne, Norges Forskningsråd, Magnus Bergvalls Stiftelse, Stiftelsen Konung Gustaf V:s 80-årsfond, Reumatikerförbundet, Alex och Eva Wallströms Stiftelse för Vetenskaplig Forskning och Utbildning, Stiftelsen Professor Nanna Svartz Fond, Innovative Medicines Initiative, Servier, Horizon 2020 Framework Programme
Award: G1974958266
OpenAlex ID: W4417261708